about
Tonic regulation of vascular permeabilityCause and consequences of the activated type I interferon system in SLESeminal CD38 is a pivotal regulator for fetomaternal tolerance.Inhibition of cellular methyltransferases promotes endothelial cell activation by suppressing glutathione peroxidase 1 protein expression.Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype.Asn563Ser polymorphism of CD31/PECAM-1 is associated with atherosclerotic cerebral infarction in a southern Han population.Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity.Catalase and superoxide dismutase conjugated with platelet-endothelial cell adhesion molecule antibody distinctly alleviate abnormal endothelial permeability caused by exogenous reactive oxygen species and vascular endothelial growth factorRNA-seq based transcriptome analysis of hepatitis E virus (HEV) and hepatitis B virus (HBV) replicon transfected Huh-7 cells.Apoptosis in capillary endothelial cells in ageing skeletal muscleIntramembrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the endothelial mechanosensory complex.Characterization of Angiogenesis and Lymphangiogenesis in Human Minor Salivary Glands with Sjögren's Syndrome.Recruitment of the adaptor protein Nck to PECAM-1 couples oxidative stress to canonical NF-κB signaling and inflammation.Microhemorrhage is an early event in the pulmonary fibrotic disease of PECAM-1 deficient FVB/n mice.Characterization of in vitro endothelial linings grown within microfluidic channels.Oral administration of marine collagen peptides prepared from chum salmon (Oncorhynchus keta) improves wound healing following cesarean section in rats.Isolation of Foreign Material-Free Endothelial Progenitor Cells Using CD31 Aptamer and Therapeutic Application for Ischemic Injury.PECAM-1 dampens cytokine levels during LPS-induced endotoxemia by regulating leukocyte traffickingSeminal CD38 Enhances Human Sperm Capacitation through Its Interaction with CD31.SIRPα/CD172a and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleen.Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model.Platelet activation in cats with hypertrophic cardiomyopathy.Dynamic shear stress regulation of inflammatory and thrombotic pathways in baboon endothelial outgrowth cellsAbsence of platelet endothelial cell adhesion molecule 1, PECAM-1/CD31, in vivo increases resistance to Salmonella enterica serovar Typhimurium in micePremature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritisEndothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31).The relationship of circulating proteins in early pregnancy with preterm birth.Immune inhibitory receptors: essential regulators of phagocyte function.Endothelial heterogeneity and adhesion molecules N-glycosylation: implications in leukocyte trafficking in inflammation.Regulation of RhoA activity by adhesion molecules and mechanotransduction.Cell surface and in vivo interaction of dendrimeric N-glycoclusters.Prolonged Cold Ischemia Time Results in Local and Remote Organ Dysfunction in a Murine Model of Vascularized Composite Transplantation.Role of PECAM-1 in radiation-induced liver inflammation.Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1.Disturbed Flow-Induced Endothelial Proatherogenic Signaling Via Regulating Post-Translational Modifications and Epigenetic Events.Polyphenolic extracts from cowpea (Vigna unguiculata) protect colonic myofibroblasts (CCD18Co cells) from lipopolysaccharide (LPS)-induced inflammation--modulation of microRNA 126.Coordination of Cellular Localization-Dependent Effects of Sumoylation in Regulating Cardiovascular and Neurological Diseases.The anti-TNF-α antibody infliximab indirectly regulates PECAM-1 gene expression in two models of in vitro blood cell activation.Diabetic retinopathy: Breaking the barrier.Characterization of CD31 expression on murine and human neonatal T lymphocytes during development and activation.
P2860
Q26863424-9104FA2C-E7F2-463F-BF20-74A653FAF1D5Q28075268-BC13FD3E-A460-4C39-A03D-5A7E86682E5EQ30619952-9E603F3C-64B0-4CFE-9E06-65FBC6DFC18EQ34075905-C77B77B0-2C49-411F-A52A-8F80C903B856Q34318454-4C23B3D0-333A-4D91-80FE-1188A15C3E4CQ34758136-F6CCBC33-3302-4551-9F34-3023C0C2C46DQ34808655-072EEA8A-926A-424A-85A4-4A4E31935229Q35077934-4101CA1C-8D0E-4B62-A6F5-1A7168C85C98Q35088268-ED8AFB4C-6A14-416F-B3BC-A1AD6AE57D1CQ35093128-503850F5-143D-42D8-99B5-6C16BD326C41Q35261533-8419876F-D0A7-4181-BAA3-65E3A87ED8F9Q35538642-6482A60A-998C-4A0B-8AF5-6BC93B2191DAQ35551178-4A8E5CFE-7D64-48B3-9B56-AF9063BFEE6AQ35552757-54C62F08-B613-4B59-AB64-A319AFE005A8Q35578817-2C3FC86C-5F8A-46AB-9950-81A1448A4363Q35607340-C25AED78-10DD-4F0F-81DF-04AB90FA468AQ35684128-065404C8-139D-4CF8-9277-EBA2A8694FFBQ35690784-7CE8B813-C2CE-48D3-B201-C6D2E5BAEB0AQ35788515-81F20B24-2C47-4FEE-A606-67D80B8E58C5Q35903177-31014B8A-555C-427F-AD08-A9295085596FQ36605868-1D2BC245-37C2-4881-940F-6D43FC7D1FC1Q36873324-414665ED-F64F-47F0-81F1-DF492F24B4A0Q36880146-98B3651D-D9D5-44FD-A42F-B23EEDC5BA0FQ36911506-BC2424CC-CE13-40CE-89E0-84CDE290BE61Q37060405-C70AD1A1-0BB0-42DD-A223-F34E7CEADD5CQ37179490-EF8AAA2E-5693-4516-9BA0-6E9189F08037Q37486145-C147D59B-6768-414B-95E8-C6EB233990A4Q37839870-A62180D7-16A5-4F4B-8E16-9554E243472FQ38085095-9253FEF1-9C2F-4BF3-BCED-E8052EED665EQ38182134-C017331F-5DA7-43E7-8865-E8F72C14D69CQ38474172-0DF645C4-90F6-42D1-B649-164ACF9AA683Q38735808-CDA169EB-AECD-4A87-9274-C3FD92707992Q38852777-65585503-EECC-4933-9E82-580E43707631Q38875899-E2B70323-78B5-4C03-97CF-2A1540F044CFQ38926909-3C2266EC-EBFF-45CC-BB6E-742A6242F9E9Q38949389-D973F766-5353-4FA7-A8CF-AA5D83F50B49Q39136019-5BDBC15E-6887-4134-89D5-F6F1AC082532Q39449989-34B82BEC-C341-4FC6-A613-A02C68EA00E9Q39451009-81612D9B-7531-4E9C-8FDF-9A7B14C6144BQ40273643-E000DEBD-79B0-47BA-9F28-223261F42D35
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
PECAM-1: conflicts of interest in inflammation.
@ast
PECAM-1: conflicts of interest in inflammation.
@en
PECAM-1: conflicts of interest in inflammation.
@nl
type
label
PECAM-1: conflicts of interest in inflammation.
@ast
PECAM-1: conflicts of interest in inflammation.
@en
PECAM-1: conflicts of interest in inflammation.
@nl
prefLabel
PECAM-1: conflicts of interest in inflammation.
@ast
PECAM-1: conflicts of interest in inflammation.
@en
PECAM-1: conflicts of interest in inflammation.
@nl
P2093
P2860
P1433
P1476
PECAM-1: conflicts of interest in inflammation.
@en
P2093
Debra K Newman
Jamie R Privratsky
Peter J Newman
P2860
P356
10.1016/J.LFS.2010.06.001
P407
P577
2010-06-10T00:00:00Z